The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - ViroPharma (NASDAQ:VPHM) updated investors last week at the JP Morgan Healthcare conference, offering 2013 guidance for lead product Cinryze, which was strong. The company expects … Continue Reading
Read nowShort Ideas - Telik, Inc. (NASDAQ:TELK) announced last Friday that the FDA granted its lead candidate, ezatiostat HCL (Telintra), orphan drug designation for the treatment of myelodysplastic syndrome … Continue Reading
Read nowQuick Picks - It looks like BGI-Shenzhen may be close to unequivocally beating out fellow bidder Illumina (NASDAQ:ILMN) in securing a buyout of Complete Genomics (NASDAQ:GNOM). Last Friday, … Continue Reading
Read nowLong Ideas - Halozyme Therapeutics (NASDAQ:HALO) will likely continue to move higher Monday after an upgrade from BMO Capital Markets, which has increased its outlook from Neutral to … Continue Reading
Read nowLong Ideas - As the world’s largest biotechnology company, with a market capitalization well on its way to $70 billion, Amgen (NASDAQ:AMGN)  represents the “old guard” of biotechnology. … Continue Reading
Read nowMost Popular - We spent the week in San Francisco for the JP Morgan and Biotech Showcase conferences, which proved invaluable for idea generation, networking, and the solidifying of some … Continue Reading
Read nowLong Ideas - PharmAthene Inc. (AMEX:PIP) announced on Thursday that the Delaware Supreme Court heard oral arguments in ongoing litigation with SIGA Technologies (NASDAQ:SIGA), and a previous ruling … Continue Reading
Read now
